Mean Reversion
Very Weak
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Very Strong
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Candel Therapeutics, Inc.
Telephone
1.617.916.5445
Address
Suite 450, 117 Kendrick Street, Needham, MA 02494
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 4.35 - 9.27
Trade Value (12mth)
US$1,599,359.00
1 week
-12.66%
1 month
9.43%
YTD
40.81%
1 year
40.04%
All time high
14.78
EPS 3 yr Growth
10.60%
EBITDA Margin
0.00%
Operating Cashflow
-$38m
Free Cash Flow Return
-45.10%
ROIC
-45.00%
Interest Coverage
-22.40
Quick Ratio
13.50
Shares Outstanding (Fully Diluted)
62m
HALO Sector
Healthcare
Next Company Report Date
01-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 16 May 26 | |
| 16 May 26 | |
| 16 May 26 | |
| 14 May 26 | |
| 14 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.31 | -1.74 | -0.72 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.31 | -1.74 | -0.72 | | | | ||
Growth | % | | | | | -101.1 | -32.9 | 58.6 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
